Cargando…

GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease

OBJECTIVE: Adult polyglucosan body disease (APBD) is an adult‐onset neurological variant of glycogen storage disease type IV. APBD is caused by recessive mutations in the glycogen branching enzyme gene, and the consequent accumulation of poorly branched glycogen aggregates called polyglucosan bodies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chown, Erin E., Wang, Peixiang, Zhao, Xiaochu, Crowder, Justin J., Strober, Jordan W., Sullivan, Mitchell A., Xue, Yunlin, Bennett, Cody S., Perri, Ami M., Evers, Bret M., Roach, Peter J., Depaoli‐Roach, Anna A., Akman, H. Orhan, Pederson, Bartholomew A., Minassian, Berge A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664254/ https://www.ncbi.nlm.nih.gov/pubmed/33034425 http://dx.doi.org/10.1002/acn3.51211

Ejemplares similares

LUBAC: a new player in polyglucosan body disease
por: Aboujaoude, Andrew, et al.
Publicado: (2021)

Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
por: Sullivan, Mitchell A., et al.
Publicado: (2017)

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011)

AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models
por: Gumusgoz, Emrah, et al.
Publicado: (2022)

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice
por: Nitschke, Silvia, et al.
Publicado: (2020)

Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism
por: Kakhlon, Or, et al.
Publicado: (2021)

Everolimus does not prevent Lafora body formation in murine Lafora disease
por: Mishra, Navin, et al.
Publicado: (2017)

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease
por: Nitschke, Felix, et al.
Publicado: (2017)

Characterization of cognitive impairment in adult polyglucosan body disease
por: Zebhauser, Paul Theo, et al.
Publicado: (2022)

A Prevalent Variant in PPP1R3A Impairs Glycogen Synthesis and Reduces Muscle Glycogen Content in Humans and Mice
por: Savage, David B, et al.
Publicado: (2008)

Glycogenin is Dispensable for Glycogen Synthesis in Human Muscle, and Glycogenin Deficiency Causes Polyglucosan Storage
por: Visuttijai, Kittichate, et al.
Publicado: (2019)

Ketogenic diet reduces Lafora bodies in murine Lafora disease
por: Israelian, Lori, et al.
Publicado: (2020)

Correction: A Prevalent Variant in PPP1R3A Impairs Glycogen Synthesis and Reduces Muscle Glycogen Content in Humans and Mice
por: Savage, David B, et al.
Publicado: (2008)

Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model
por: Donohue, Katherine J., et al.
Publicado: (2023)

GYG1: A distal myopathy with polyglucosan bodies
por: Nicolau, Stefan, et al.
Publicado: (2020)

A Case of Adult Polyglucosan Body Disease
por: Lee, Seung-Yeob, et al.
Publicado: (2007)

Polyglucosan bodies in medullary catecholaminergic neurones in SUDEP
por: Patodia, Smriti, et al.
Publicado: (2021)

miR-140-5p Aggravates Insulin Resistance via Directly Targeting GYS1 and PPP1CC in Insulin-Resistant HepG2 Cells
por: Li, Xuemei, et al.
Publicado: (2021)

Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality
por: Fredriksson, Jenny, et al.
Publicado: (2007)

Hepatic glycogen synthase (GYS2) deficiency: seven novel patients and seven novel variants
por: Kamenets, Elena A., et al.
Publicado: (2020)

Protein targeting to glycogen is a master regulator of glycogen synthesis in astrocytes
por: Ruchti, E., et al.
Publicado: (2016)

GYG1 gene mutations in a family with polyglucosan body myopathy
por: Fanin, Marina, et al.
Publicado: (2015)

First Report on Fetal Cerebral Polyglucosan Bodies in Mucopolysaccharidosis Type VII
por: Kadhim, Hazim, et al.
Publicado: (2017)

Abnormal glycogen in astrocytes is sufficient to cause adult polyglucosan body disease
por: Dainese, Linda, et al.
Publicado: (2013)

Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
por: Mitra, Sharmistha, et al.
Publicado: (2023)

A novel variant of RBCK1 gene causes mild polyglucosan myopathy
por: AlAnzi, Talal, et al.
Publicado: (2022)

Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model
por: Moreno-Estellés, Mireia, et al.
Publicado: (2023)

Novel GYS2 mutations in a Japanese patient with glycogen storage disease type 0a
por: Iijima, Hiroyuki, et al.
Publicado: (2021)

Novel GBE1 mutation in a Japanese family with adult polyglucosan body disease
por: Harigaya, Yasuo, et al.
Publicado: (2017)

Proteomic investigations of adult polyglucosan body disease: insights into the pathobiology of a neurodegenerative disorder
por: Abraham, Joseph R., et al.
Publicado: (2023)

Pediatric patient with hyperketotic hypoglycemia diagnosed with glycogen synthase deficiency due to the novel homozygous mutation in GYS2
por: Szymańska, Edyta, et al.
Publicado: (2015)

HOIL‐1 ubiquitin ligase activity targets unbranched glucosaccharides and is required to prevent polyglucosan accumulation
por: Kelsall, Ian R, et al.
Publicado: (2022)

Pathomorphogenesis of Glycogen-Ground Glass Hepatocytic Inclusions (Polyglucosan Bodies) in Children after Liver Transplantation
por: Callea, Francesco, et al.
Publicado: (2022)

Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult mice
por: Xirouchaki, Chrysovalantou E., et al.
Publicado: (2016)

Polyglucosan body myopathy 1 may cause cognitive impairment: a case report from China
por: Chen, Lin, et al.
Publicado: (2021)

Proctalgia and constipation secondary to hypertrophic polyglucosan inclusion body myopathy of the internal anal sphincter: a case report
por: Panagiotopoulou, Ioanna G, et al.
Publicado: (2018)

GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma
por: Chen, Shi-lu, et al.
Publicado: (2020)

Lupin protein isolate improves insulin sensitivity and steatohepatitis in vivo and modulates the expression of the Fasn, Gys2, and Gsk3b genes
por: Soto‐Luna, Irma Catalina, et al.
Publicado: (2021)

On the Problem of Double-Filtering in PPP-RTK
por: Khodabandeh, A., et al.
Publicado: (2022)

Retinal Phenotyping of a Murine Model of Lafora Disease
por: Vincent, Ajoy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kvopah19tre12lptcmfj1gjitd